AstraZeneca and Oracle to build AI platform for clinical trial recruitment and safety monitoring
AstraZeneca and Oracle announced on 20 October that they will use AI and real-world patient data to speed up trial patient recruitment. The agreement also covers safety monitoring.
Who is affected and how
- pharmaceuticals
- AI recruitment based on real-world patient data could shorten trial start-up times and serve as a model for redesigning trial processes.
- doctor
- Trial sites should expect new enquiries arising from data-driven patient identification.
- health IT
- Integrating real-world patient data with cloud platforms raises the infrastructure demands of clinical research.
Sources
- AstraZeneca Partners With Oracle to Refine Clinical Research With AIwsj · Oct 20, 2026
- AstraZeneca and Oracle Join Forces to Bring AI Into Clinical Trials and Transform Patient Carekingy ai · Oct 20, 2026
- AZ and Oracle team up on AI platform for clinical trials | pharmaphorumpharmaphorum.com · Oct 20, 2026
- AstraZeneca Partners With Oracle to Use AI in Clinical Trials - WSJwsj.com · Oct 20, 2026
- AstraZeneca partners with Oracle on AI clinical research By Investing.cominvesting.com · Oct 20, 2026
- AstraZeneca and Oracle Launch AI Partnership to Improve Clinical Trials and Patient Carefinance.yahoo.com · Oct 20, 2026
- The future of medicine: How AI could transform patient careynetnews · Oct 21, 2026
- AstraZeneca partners with Oracle for AI-driven clinical trialspharma.economictimes.indiatimes.com · Oct 21, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.